Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Heinemann

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|January 16, 2002
Gene patents: are they socially acceptable monopolies, essential for drug discovery? -- replyJack A Heinemann
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 13, 2012
Food and chemical toxicologyJack A Heinemann
Environment International|June 9, 2019
Should dsRNA treatments applied in outdoor environments be regulated?Jack A Heinemann
Nature Biotechnology|May 10, 2008
Off the rails or on the mark?Jack A Heinemann
Nature Biotechnology|December 11, 2007
GM soybeans--revisiting a controversial formatJack A Heinemann, Terje Traavik
Nature Biotechnology|September 2, 2004
Problems in monitoring horizontal gene transfer in field trials of transgenic plantsJack A Heinemann, Terje Traavik
Applied and Environmental Microbiology|May 5, 2006
The general secretory pathway of Burkholderia gladioli pv. agaricicola BG164R is necessary for cavity disease in white button mushroomsPiklu Roy Chowdhury, Jack A Heinemann
Environment International|June 1, 2011
Molecular profiling--a tool for addressing emerging gaps in the comparative risk assessment of GMOsJack A Heinemann, Brigitta Kurenbach, David Quist
Environment International|May 12, 2012
Observational science in the environmental risk assessment and management of GMOsJack A Heinemann, O A El-Kawy
Drug Discovery Today|May 20, 2004
Shooting the messenger of antibiotic resistance: plasmid elimination as a potential counter-evolutionary tacticCarlos F Amábile-Cuevas, Jack A Heinemann
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|January 16, 2002
Gene patents: are they socially acceptable monopolies, essential for drug discovery? -- replyJack A Heinemann
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 13, 2012
Food and chemical toxicologyJack A Heinemann
Environment International|June 9, 2019
Should dsRNA treatments applied in outdoor environments be regulated?Jack A Heinemann
Nature Biotechnology|May 10, 2008
Off the rails or on the mark?Jack A Heinemann
Nature Biotechnology|December 11, 2007
GM soybeans--revisiting a controversial formatJack A Heinemann, Terje Traavik
Nature Biotechnology|September 2, 2004
Problems in monitoring horizontal gene transfer in field trials of transgenic plantsJack A Heinemann, Terje Traavik
Applied and Environmental Microbiology|May 5, 2006
The general secretory pathway of Burkholderia gladioli pv. agaricicola BG164R is necessary for cavity disease in white button mushroomsPiklu Roy Chowdhury, Jack A Heinemann
Environment International|June 1, 2011
Molecular profiling--a tool for addressing emerging gaps in the comparative risk assessment of GMOsJack A Heinemann, Brigitta Kurenbach, David Quist
Environment International|May 12, 2012
Observational science in the environmental risk assessment and management of GMOsJack A Heinemann, O A El-Kawy
Drug Discovery Today|May 20, 2004
Shooting the messenger of antibiotic resistance: plasmid elimination as a potential counter-evolutionary tacticCarlos F Amábile-Cuevas, Jack A Heinemann
Pageof 5